Page last updated: 2024-11-11

spheroidene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

spheroidene: one of main carotenoids in Rhodopseudomonas spheroides; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

spheroidene : The cartenoid ether that is the methyl ether of 3,4-didehydro-1,2,7',8'-tetrahydro-psi,psi-caroten-1-ol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6368932
CHEBI ID35330
SCHEMBL ID39207
MeSH IDM0047296

Synonyms (12)

Synonym
LMPR01070119
13836-61-8
spheroidene
(6e,10e,12e,14e,16e,18e,20e,22e,24e,26e,28e)-31-methoxy-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,10,12,14,16,18,20,22,24,26,28-dodecaene
3,4-didehydro-1,2,7',8'-tetrahydro-1-methoxy-psi,psi-carotene
all-trans-spheroidene
1-methoxy-3,4-didehydro-1,2,7',8'-tetrahydro-psi,psi-carotene
CHEBI:35330
SCHEMBL39207
Q27116458
7OT ,
DTXSID701318186

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carotenoid ether
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
spheroidene and spheroidenone biosynthesis612

Research

Studies (58)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (3.45)18.7374
1990's14 (24.14)18.2507
2000's19 (32.76)29.6817
2010's21 (36.21)24.3611
2020's2 (3.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.46 (24.57)
Research Supply Index4.13 (2.92)
Research Growth Index5.29 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other61 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]